The relationship between inhibition of phosphofructokinase activity and the mode of action of trivalent organic antimonials on Schistosoma mansoni.
D000818:Animals; D000965:Antimony / Q000031:analogs & derivatives; D000981:Antiprotozoal Agents; D001557:Benzenesulfonates; D005634:Fructose-Bisphosphate Aldolase; D005636:Fructosephosphates; D005947:Glucose; D006019:Glycolysis; D009942:Organometallic Compounds; D010732:Phosphofructokinase-1; D025221:Phosphofructokinases; D010770:Phosphotransferases; D012547:Schistosoma; D012550:Schistosoma mansoni / Q000378:metabolism*; D012552:Schistosomiasis; D013644:Tartrates
D000981:Antiprotozoal Agents; D001557:Benzenesulfonates; D005636:Fructosephosphates; D009942:Organometallic Compounds; D013644:Tartrates; C077725:Stibophen; C027618:fructose-6-phosphate; D000965:Antimony; D010770:Phosphotransferases; D025221:Phosphofructokinases; D010732:Phosphofructokinase-1; D005634:Fructose-Bisphosphate Aldolase; D005947:Glucose; C029768:tartaric acid
ANTIMONY/related compounds; SCHISTOSOMA MANSONI/metabolism; TRANSPHOSPHORYLASES
Ann Trop Med Parasitol. 1953 Mar;47(1):26-43
13041129
J Biol Chem. 1955 Aug;215(2):495-506
13242546
Pharmacol Rev. 1956 Mar;8(1):89-135
13335490
J Pharmacol Exp Ther. 1951 Feb;101(2):210-29
14814617
Exp Parasitol. 1955 Jan;4(1):40-4
13231842
J Gen Physiol. 1950 May 20;33(5):475-95
15422103
Br J Pharmacol Chemother. 1953 Dec;8(4):431-4
13115633